Synthesis of fenoprofen and gemfibrozil styrene-maleic acid copolymer conjugates

Acta Pharmaceutica

Volumn 55, Issue 2, 2005, Pages 169-176

  Zovko, Marijana ^a   Barbarić, Monika ^a   Zorc, Branka ^a   Hafner, Anita ^a   Filipović Grčić, Jelena ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Fenoprofen; Gemfibrozil; Macromolecular prodrug; Polymer drug conjugate; Styrene maleic acid anhydride copolymer

Indexed keywords

2 AMINOETHYLAMIDE; AMINO ACID DERIVATIVE; ETHYLENEDIAMINE DERIVATIVE; FENOPROFEN; GEMFIBROZIL; POLYMER; PRODRUG; STYRENE MALEIC ANHYDRIDE COPOLYMER; UNCLASSIFIED DRUG;

ARTICLE; DRUG CONJUGATION; DRUG STRUCTURE; DRUG SUBSTITUTION; DRUG SYNTHESIS; HYDROPHILICITY; LIPOPHILICITY; PLASMA HALF LIFE;

EID: 22244491324     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. K. R. Lu, J. G. Shiah, S. Sakuma, P. Kopeckova and J. Kopecek, Design of novel bioconjugates for targeted drug delivery, J. Control. Rel. 78 (1992) 165-173.
2. R. J. Christie and D. W. Grainger, Design strategies to improve soluble macromolecular delivery constructs, Adv. Drug Del. Rev. 55 (2003) 421-437.
3. M. C. Garnett, Targeted drug conjugates: principles and progress, Adv. Drug. Del. Rev. 53 (2001) 171-216.
4. M. M. Muratov, Z. N. Savinkova and S. N. Vereschagina, Hygienic assessment of acetate fibers with an adjuvant »stiromal« copolymer and that of fabrics made of them, Gig. Sanit. 9 (1975) 54-57.
5. C. L. Winek and J. J. Burgun, Acute and subacute toxicology and safety evaluation of SMA 1440-H resin, Clin. Toxicol. 10 (1977) 255-260.
6. S. K. Guha, G. Singh, S. Ansari, S. Kumar, A. J. Srivastava, V. Koul, H. C. Das, R. L. Malhotra and S. K. Dastt, Phase II clinical trial of a vas deferens injectable contraceptive for the male, Contraception 56 (1997) 245-250.
7. S. K. Guha, G. Singh, A. J. Srivastava, H. C. Das, J. C. Bhardwaj, V. Mathur, V. Koul, R. L. Malhotra and S. K. Das, Two-year clinical efficacy trial with dose variations of a vas deferens injectable contraceptive for the male, Contraception 58 (1998) 165-174.
8. K. Shima, K. Mizojiri and R. Yamamoto, Interaction of some pharmaceuticals with synthetic macromolecules. 2. Binding of pyrazolone- and phenothiazine derivatives with styrene-maleic acid anhydride copolymer, Yakugaku Zasshi 90 (1970) 469-474;
9. ref. Chem. Abstr. 73 (1970) 28832d.
10. K. Shima, S. Ichihashi and R. Yamamoto, Interaction of some pharmaceuticals with synthetic macromolecules. 4. Binding of barbituric acid-, hydroxybenzoic acid-, and xantine derivatives, with styrene-maleic acid anhydride copolymer, Yakugaku Zasshi 90 (1970) 730-735;
11. ref. Chem. Abstr. 73 (1970) 59278g.
12. I. Kalčić, B. Zorc and I. Butula, Macromolecular prodrugs. VII. Polymer-dopamine conjugates, Int. J. Pharm. 136 (1996) 31-36.
13. J. S. Patel, S. V. Patel, N. P. Talpada and H. A. Patel, Bioactive polymers: Synthesis, release study and antimicrobial properties of polymer bound ampicillin, Angew. Makromol. Chem. 271 (1999) 24-27.
14. H. A. Patel, D. A. Raval, D. Madamwar and S. P. Patel, Polymeric prodrug: Synthesis, release study and antimicrobial property of poly(styrene-co-maleic anhydride)-bound acriflavine, Angew. Makromol. Chem. 263 (1998) 25-30.
15. J. H. Jeong, Y. S. Byoun and Y. S. Lee, Chemical modification of poly(styrene-alt-maleic anhydride) with antimicrobial 4-aminobenzoic acid and 4-hydroxybenzoic acid, J. Ind. Eng. Chem. 7 (2001) 310-315.
16. J. H. Jeong, Y. S. Byoun and Y. S. Lee, Poly(styrene-alt-maleic anhydride)-4-aminophenol conjugate: synthesis and antibacterial activity, Reac. Funct. Polym. 50 (2002) 257-263.
17. H. Maeda, Pharmacological Uniqueness and Clinical Effects, in Neocarzinostatin: The Past, Present and Future of Anticancer Drugs (Eds. H. Maeda, K. Edo and N. Ishida), Springer, Tokyo 1997, pp. 205-226.
18. F. M. Veronese and M. Morpurgo, Bioconjugation in pharmaceutical chemistry, Farmaco 54 (1999) 497-516.
19. H. Maeda, SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy, Adv. Drug Del. Rev. 46 (2001) 169-185.
20. th ed., Lippincott Williams & Wilkins, Philadelphia 2002.
21. B. Zorc and I. Butula, Macromolecular prodrugs. III. Esters of fenoprofen and probenecid, Acta Pharm. 44 (1994) 103-108.
22. M. Lovrek, B. Zorc, B. Boneschans and I. Butula, Macromolecular prodrugs. VIII. Synthesis of polymer-gemfibrozil conjugates, Int. J. Pharm. 200 (2000) 59-66.
23. M. Zovko, B. Zorc, M. Lovrek and B. Boneschans, Macromolecular prodrugs. IX. Synthesis of polymer-fenoprofen conjugates, Int. J. Pharm. 228 (2001) 129-138.
24. T. Van der Merwe, B. Boneschans, B. Zorc, J. Breytenbach and M. Zovko, Macromolecular pro-drugs. X. Kinetics of fenoprofen release from PHEA-fenoprofen conjugate, Int. J. Pharm. 241 (2002) 223-230.
25. B. Boneschans, T. van der Merwe, A. Wessels and B. Zorc, Validation of the HPLC method for model determination of fenoprofen in conjugates with PHEA, Acta Pharm. 52 (2002) 37-43.
26. A. Martinac, J. Filipović-Grčić, M. Barbarić, B. Zorc, D. Voinovich and I. Jaľenjak, Gemfibrozil encapsulation and release from microspheres and macromolecular conjugates, Eur. J. Pharm. Sci. 17 (2002) 207-216.
27. I. Kalčić, M. Zovko, M. Jadrijević-Mladar Takač, B. Zorc and I. Butula, Synthesis and reactions of some azole carboxylic acid derivatives, Croat. Chem. Acta 76 (2003) 217-228.
28. M. Lovrek, M. Jadrijević-Mladar Takač, B. Zorc and B. Boneschans, Gemfibrozil ester and amide derivatives - synthesis, spectroscopic characterisation and QSPR, Pharmazie 55 (2000) 811-816.
29. M. Kovač-Filipović, M. Tomašković, V. Srića, A. Alajbeg and V. Jarm, High degrees monomer conversion in heterogenous copolymerization of styrene and maleic anhydride in toluene, Polimeri 10 (1989) 157-159.